HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
Sequencing BCMA Myeloma Therapies
Sequencing BCMA Myeloma Therapies image
Immunotherapy (CAR T, Bispecifics and more) Treatment Chapter
event Apr 11, 2023 / 01:00PM - 02:00PM EDT

Event Description

Let's learn together what we know about sequencing BCMA therapies, and what there's left to learn. As more immunotherapies targeting BCMA on cancerous myeloma plasma cells continue to be develop, there is question about which combination of these treatments is most efficacious, and what precautions need to be taken when using such similar targeted therapies. Join Dr. Josh Richter, a myeloma specialist, as he shares information regarding this topic.

Schedule & Agenda

The panelist Audrey Burton-Bethke
Introductions
1:00 PM
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Dr. Joshua Richter.

The panelist Joshua Richter, MD
Presentation
1:05 PM
Joshua Richter, MD

Dr. Joshua Richter shares about sequencing BCMA therapies.

 

 

person
Questions and Answers
1:35 PM
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Joshua Richter, MD
Joshua Richter, MD

Joshua Richter, MD, is Associate Professor of Medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology. He is the director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai. Dr. Richter treats patients with plasma cell dyscrasias, including multiple myeloma and related diseases such as AL amyloidosis, plasma cell leukemia, and Waldenstrom’s Macroglobulinemia. Dr. Richter has extensive experience with clinical trials focused on novel therapies, including antibody therapy and immunotherapy for a precision medicine approach. He has published extensively on these topics and has been invited to speak regionally, nationally, and also internationally. He has been published in journals such as the New England Journal of Medicine, Blood, and the Journal of Clinical Oncology.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube